Marcus Sidney Shaker MD
Asthma & Allergic Conditions
Associate Professor, Pediatrics, Geisel School of Medicine
Join to View Full Profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-653-9885
Fax+1 603-640-6826
Dr. Shaker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterResidency, Pediatrics, 1998 - 2001
University of Virginia School of MedicineClass of 1998
Certifications & Licensure
NH State Medical License 2004 - 2026
VT State Medical License 2005 - 2026
DE State Medical License 2003 - 2005
MD State Medical License 2003 - 2005
VA State Medical License 1998 - 2004
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- Medical Management of Rhinitis: Medication Options.Sylvia Li, Marcus Shaker, Anju Peters
Immunology and Allergy Clinics of North America. 2026-02-01 - Change, Career Transitions, and Retirement in Allergy-Immunology.Melinda Rathkopf, Ray S Davis, Dana V Wallace, Thomas A Fleisher, Michael E Conti
The Journal of Allergy and Clinical Immunology. in Practice. 2026-01-01 - Open access to life-saving medication in allergy-immunology: The predicate device-Past, present, and future.Marcus Shaker, Matthew R Shaker, Marylee Verdi
Annals of Allergy, Asthma & Immunology. 2026-01-01
Journal Articles
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemMatthew Greenhawt, Marcus S Shaker, Annals of Allergy, Asthma & Immunology
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesMatthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
Authored Content
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemApril 2020
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020
- Engaging Patient Partners in State of the Art Allergy Care: Finding Balance When Discussing RiskFebruary 2020
Press Mentions
Omalizumab vs Oral Immunotherapy: No Clear WinnerMarch 12th, 2025- Smiles Abound at AAAAI 2022March 7th, 2022
Original Article A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination StrategiesMarch 9th, 2021
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
